January 2016
Ariticle in MED INN Magazin der Medizinischen Universität Innsbruck: “Das mutierte Wächter-Gen [The mutated guardian of the genome].” (in German) article
October 2015
Ariticle in FORUM MEDIZIN. Die Zeitung für medizinische Forschung, Lehre und Krankenversorgung. Supplement to Tiroler Tageszeitung [Tyrolean daily newspaper]: “Eierstockkrebs: Innovative Therapie. Erste Ergebnisse bei EU-Projekt GANNET53. [Ovarian cancer: innovative therapy. First results from EU project GANNET53].” (in German) article
August 2015
Ariticle in Der STANDARD [Austrian daily newspaper]: “Eierstockkrebs: Therapie für Frauen, die sonst chancenlos sind“ [Ovarian cancer: a therapy for woman with rare changes]; (in German) link
June 2015
Press release by Synta Pharmaceuticals: “First Patient Enrolled in Phase 2 Portion of GANNET53 Study of Ganetespib in Ovarian Cancer” article
April 2015
Article in “Gyn-Aktiv” [Austrian gynaecological journal], issue 02/2015: “Status aktueller AGO Studien: GANNET53 [Status of ongoing AGO trials]“
December 2014
Article in “TIROLER BAUERNZEITUNG” [Tyrolean farmers’ journal], issue 50: “Frauen und Krebs – ein höchst aktuelles Thema“ [women and cancer – a most topical subject] (in German) article
December 2014
Article in DER MEDICUS, Journal der Hochschülerschaft an der Medizinischen Universität Innsbruck [journal of the students association at Innsbruck Medical University]; interview with Nicole Concin; issue 03/2014 (in German) article
July 2014
Article in DIE PRESSE [Austrian daily newspaper]: “Krebsgen unter der Lupe” [cancer gene under the microscope] (in German) article
May 2014
Article in GYN-AKTIV [Austrian gynaecological journal], issue 02/2014: “Auswahl aktueller AGO Studien” [Selected AGO trials] (in German) article
May 2014
Article in TIROLER TAGESZEITUNG [Austrian daily newspaper]: „Mit neuem Medikament den stillen Krebs aufhalten” [Stop the silent cancer with new drug] (in German); Weblink: http://www.tt.com/lebensart/gesundheit/8385658-91/mit-neuem-medikament-den-stillen-krebs-aufhalten.csp
May 2014
Article in ECHO – Tirols erstes Nachrichtenmagazin [Tyrolean monthly magazine], issue 05/2014 (in German): “Innovative Wege” [innovative approaches] article
January 2014
Press release by SYNTA PHARMACEUTICALS press release
April 2014
Special supplement in DER STANDARD [Austrian daily newspaper]: “FFG Forschungsefolge” [Austrian Research Promotion Agency: achievements in research] (in German)
April 2014
Annual Report 2013 of the Austrian Research Promotion Agency FFG; presentation of the GANNET53 project; https://www.ffg.at/sites/default/files/allgemeine_downloads/ffg%20allgemein/presseunterlagen/ffg_jahresbericht_2013.pdf
December 2013
Article in the online magazine “JOURNAL ONKOLOGIE” [oncologic journal]; Weblink: http://www.journalonko.de/newsview.php?id=7053
December 2013
Article in DER STANDARD [Austrian daily newspaper] (in German): “Rasterfandung in Krebszellen” [Dragnet investigation in cancer cells] (in German) article
November 2013
Press information by STANDORTAGENTUR TIROL [Public agency of the Province of Tyrol/Austria for economic and scientific affairs] (in German) press information
November 2013
Press release by the GANNET53 CONSORTIUM (in German) press release
Events / Presentations
January 2016
GANNET53 Consortium Meeting, Frankfurt, Germany
May 2015
ASCO Meeting 2015, Chicago, Illinois; Abstract and poster presented by Prof. Isabelle Ray-Coquard (P7): “Part I of GANNET53: A multicentre phase I/II trial of the Hsp90 inhibitor Ganetespib (G) combined with weekly Paclitaxel (P) in women with high-grade serous, high-grade endometrioid, or undifferentiated, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer”. Weblink: http://meetinglibrary.asco.org/content/112111?media=vm&poster=1.
April 2015
8. International Charité-Mayo-Conference: Updates in Gynecology: A Global Perspective; Berlin/Germany; Lecture held by Prof.Nicole Concin: “p53: targeting ovarian cancer at its roots”
April 2015
Lecture held by Prof Nicole Concin at the IOR - Institute of Oncology Research, Bellinzona, Switzerland: “Targeting p53: attacking ovarian cancer at the roots”
March 2015
9e Rencontres Scientifiques du GINECO in Paris/France; lecture held by Nicole Concin (P1); Title: “Targeting p53: attacking ovarian cancer cell at the roots”
January 2015
GANNET53 Consortium Meeting, Leuven, Belgium. brochure
November 2014
Forum Land [lecture series organised by the Tyrolean Farmers’ Association]; lecture held by Nicole Concin in Pettna, Tyrol, Austria: “Neue Therapien bei Eierstockkrebs”[new therapies for ovarian cancer]
September 2014
Fourth Gynaecological cancer academy (GCA) Workshop in Frankfurt/Germany, Lecture held by Nicole Concin: “Inhibiting the gain-of-function of mutated p53”
June 2014
16th International p53 Workshop, Stockholm, Sweden. Lecture held by Ute M. Moll (P11/UMG-GOE): “Exploiting tumor cell addiction to mutant p53 by pharmacological inhibition of the HSP90 chaperone axis in knocking mouse moddels”; Weblink: www.p53sweden2014.com
April 2014
GANNET53 Kick-off Meeting Phase I, Lyon, France. agenda
March 2014
Ringvorlesung Gendermedizin Onkologie [lecture series on oncological gender medicine] at Medical University of Innsbruck, Austria; Lecture given by Nicole Concin to a non-scientific audience: „p53-basierte Therapiestrategien bei Patientinnen mit Ovarialkarzinom“ [p53-based therapies for patients with ovarian cancer] program
November 2013
Tiroler Standort Lunch in Vienna, Austria [event organized by the province of Tyrol to foster Tyrol as as econcomic and scientific location]; Nicole Concin presents the GANNET53 project: “GANNET53 - Eierstockkrebs innovativ therapieren“ [GANNET53 – innovative therapy for ovarian cancer] program
October 2013
17th Oncologic Summit, Loas, Tyrol, Austria. Lecture: “The tumor-promoting aspect of mutated p53 - therapeutic implications” program
October 2013
18th International Meeting of the European Society of Gynaecological Oncology (ESGO), Liverpool, UK. poster
October 2013
GANNET53 Kick-off Meeting, Frankfurt, Germany. agenda